Also, the frequent administration of recombinant erythropoietin (rhuEPO) for the correction of end-stage renal disease-induced anemia is considered to be one of the causes of LT apoptosis, especially CD4+ LTs [59]. This evidence concerns the gene CD4 and anemia.